Avanir Sues Rivals Over Plans For Generic Neurological Drug
Avanir Pharmaceuticals Inc. sued a handful of other drug companies in Delaware federal court on Wednesday, alleging their plans to make a generic treatment for a condition associated with neurological disorders...To view the full article, register now.
Already a subscriber? Click here to view full article